{"text": ["Greek", "govt", "alleges", "official", "ties", "to", "drug", "bribery", "scandal"], "created_at": "2018-02-05 22:37:45"}
{"text": ["3", "Top", "Pharmaceutical", "Stocks", "to", "Buy", "Now"], "created_at": "2018-02-05 16:11:10"}
{"text": ["3", "Top", "Pharmaceutical", "Stocks", "to", "Buy", "Now"], "created_at": "2018-02-05 16:11:10"}
{"text": ["Novartis\u2019s", "Valuations", "after", "Its", "4Q17", "Earnings"], "created_at": "2018-02-05 15:33:27"}
{"text": ["Novartis\u2019s", "4Q17", "Earnings:", "Alcon", "Business"], "created_at": "2018-02-05 14:02:47"}
{"text": ["GSK", "Is", "Focused", "on", "Innovative", "Assets", "in", "Oncology", "Research", "Pipeline"], "created_at": "2018-02-05 14:00:03"}
{"text": ["Novartis\u2019s", "4Q17", "Earnings:", "Sandoz", "Business"], "created_at": "2018-02-05 12:34:46"}
{"text": ["How", "Biogen\u2019s", "Biosimilars", "and", "Interferons", "Performed", "in", "4Q17"], "created_at": "2018-02-05 12:34:39"}
{"text": ["Multiple", "Myeloma", "May", "Be", "Strong", "Growth", "Area", "for", "GlaxoSmithKline"], "created_at": "2018-02-05 12:30:03"}
{"text": ["The", "Swiss", "Stock", "Market", "Continues", "To", "Sell-Off"], "created_at": "2018-02-05 12:11:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Continues", "To", "Sell-Off"], "created_at": "2018-02-05 12:11:00"}
